- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Workstation automates visualization and flight-path generation
Easy-to-use clinical extras for TeraRecon’s Aquarius workstation line are showing on the RSNA exhibit floor. The enhanced Aquarius Workstation 3.3 includes a segmentation feature that extracts coronary arteries and other blood vessels and a stretched multiplanar reconstruction that calculates the extent of vessel stenosis with a single mouse click.
Easy-to-use clinical extras for TeraRecon's Aquarius workstation line are showing on the RSNA exhibit floor. The enhanced Aquarius Workstation 3.3 includes a segmentation feature that extracts coronary arteries and other blood vessels and a stretched multiplanar reconstruction that calculates the extent of vessel stenosis with a single mouse click.
The workstation also has an automated 3D viewer, automatic colon segmentation, and semi-automatic flight-path generation.
The Aquarius Workstation 3.3 builds on previous Aquarius real-time 3D visualization technology for viewing CT and MR images. Cubic viewing for lesions, polyps, and other regions of interest is featured along with select-and-hide for removing bone from abdominal aortic aneurysms. Runoff studies are standard segmentation and measurement tools.
Other features include real-time interactive volume rendering, automatic fly-through navigation, and simultaneous linked oblique multiplanar reformatted views for time-dependent multiphase MR and CT angiography. Double-oblique MPR, maximum intensity projection, slab MIP, MinIP, RaySum, and Perspective 3D are offered for 3D reconstruction. Curved planar reformats visually flatten curved or convoluted blood vessels.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
